269 related articles for article (PubMed ID: 29165639)
1. Human cancer tissues exhibit reduced A-to-I editing of miRNAs coupled with elevated editing of their targets.
Pinto Y; Buchumenski I; Levanon EY; Eisenberg E
Nucleic Acids Res; 2018 Jan; 46(1):71-82. PubMed ID: 29165639
[TBL] [Abstract][Full Text] [Related]
2. Landscape of tissue-specific RNA Editome provides insight into co-regulated and altered gene expression in pigs (
Adetula AA; Fan X; Zhang Y; Yao Y; Yan J; Chen M; Tang Y; Liu Y; Yi G; Li K; Tang Z
RNA Biol; 2021 Oct; 18(sup1):439-450. PubMed ID: 34314293
[TBL] [Abstract][Full Text] [Related]
3. Clinical Relevance of Noncoding Adenosine-to-Inosine RNA Editing in Multiple Human Cancers.
Gu T; Fu AQ; Bolt MJ; White KP
JCO Clin Cancer Inform; 2019 Jun; 3():1-8. PubMed ID: 31162949
[TBL] [Abstract][Full Text] [Related]
4. Combinatory RNA-Sequencing Analyses Reveal a Dual Mode of Gene Regulation by ADAR1 in Gastric Cancer.
Cho CJ; Jung J; Jiang L; Lee EJ; Kim DS; Kim BS; Kim HS; Jung HY; Song HJ; Hwang SW; Park Y; Jung MK; Pack CG; Myung SJ; Chang S
Dig Dis Sci; 2018 Jul; 63(7):1835-1850. PubMed ID: 29691780
[TBL] [Abstract][Full Text] [Related]
5. Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers.
Wang Y; Xu X; Yu S; Jeong KJ; Zhou Z; Han L; Tsang YH; Li J; Chen H; Mangala LS; Yuan Y; Eterovic AK; Lu Y; Sood AK; Scott KL; Mills GB; Liang H
Genome Res; 2017 Jul; 27(7):1112-1125. PubMed ID: 28411194
[TBL] [Abstract][Full Text] [Related]
6. Detection of canonical A-to-G editing events at 3' UTRs and microRNA target sites in human lungs using next-generation sequencing.
Soundararajan R; Stearns TM; Griswold AL; Mehta A; Czachor A; Fukumoto J; Lockey RF; King BL; Kolliputi N
Oncotarget; 2015 Nov; 6(34):35726-36. PubMed ID: 26486088
[TBL] [Abstract][Full Text] [Related]
7. Conserved microRNA editing in mammalian evolution, development and disease.
Warnefors M; Liechti A; Halbert J; Valloton D; Kaessmann H
Genome Biol; 2014 Jun; 15(6):R83. PubMed ID: 24964909
[TBL] [Abstract][Full Text] [Related]
8. The adaptive potential of RNA editing-mediated miRNA-retargeting in cancer.
Tassinari V; Cesarini V; Silvestris DA; Gallo A
Biochim Biophys Acta Gene Regul Mech; 2019 Mar; 1862(3):291-300. PubMed ID: 30605729
[TBL] [Abstract][Full Text] [Related]
9. Redirection of silencing targets by adenosine-to-inosine editing of miRNAs.
Kawahara Y; Zinshteyn B; Sethupathy P; Iizasa H; Hatzigeorgiou AG; Nishikura K
Science; 2007 Feb; 315(5815):1137-40. PubMed ID: 17322061
[TBL] [Abstract][Full Text] [Related]
10. Adenosine-to-Inosine RNA Editing Enzyme ADAR and microRNAs.
Yuting K; Ding D; Iizasa H
Methods Mol Biol; 2021; 2181():83-95. PubMed ID: 32729076
[TBL] [Abstract][Full Text] [Related]
11. RNA Editing Modulates Human Hepatic Aryl Hydrocarbon Receptor Expression by Creating MicroRNA Recognition Sequence.
Nakano M; Fukami T; Gotoh S; Takamiya M; Aoki Y; Nakajima M
J Biol Chem; 2016 Jan; 291(2):894-903. PubMed ID: 26601943
[TBL] [Abstract][Full Text] [Related]
12. Frequency and fate of microRNA editing in human brain.
Kawahara Y; Megraw M; Kreider E; Iizasa H; Valente L; Hatzigeorgiou AG; Nishikura K
Nucleic Acids Res; 2008 Sep; 36(16):5270-80. PubMed ID: 18684997
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of human small RNA sequencing data provides insights into expression profiles and miRNA editing.
Gong J; Wu Y; Zhang X; Liao Y; Sibanda VL; Liu W; Guo AY
RNA Biol; 2014; 11(11):1375-85. PubMed ID: 25692236
[TBL] [Abstract][Full Text] [Related]
14. A-to-I RNA Editing Up-regulates Human Dihydrofolate Reductase in Breast Cancer.
Nakano M; Fukami T; Gotoh S; Nakajima M
J Biol Chem; 2017 Mar; 292(12):4873-4884. PubMed ID: 28188287
[TBL] [Abstract][Full Text] [Related]
15. Systematic identification of edited microRNAs in the human brain.
Alon S; Mor E; Vigneault F; Church GM; Locatelli F; Galeano F; Gallo A; Shomron N; Eisenberg E
Genome Res; 2012 Aug; 22(8):1533-40. PubMed ID: 22499667
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA Editing Detection and Function: A Combined In Silico and Experimental Approach for the Identification and Validation of Putative Oncogenic Targets.
Tassinari V; Cesarini V; Silvestris DA; Scafidi A; Cucina L; Gallo A
Methods Mol Biol; 2021; 2181():253-267. PubMed ID: 32729085
[TBL] [Abstract][Full Text] [Related]
17. The landscape of miRNA editing in animals and its impact on miRNA biogenesis and targeting.
Li L; Song Y; Shi X; Liu J; Xiong S; Chen W; Fu Q; Huang Z; Gu N; Zhang R
Genome Res; 2018 Jan; 28(1):132-143. PubMed ID: 29233923
[TBL] [Abstract][Full Text] [Related]
18. RNA editing of human microRNAs.
Blow MJ; Grocock RJ; van Dongen S; Enright AJ; Dicks E; Futreal PA; Wooster R; Stratton MR
Genome Biol; 2006; 7(4):R27. PubMed ID: 16594986
[TBL] [Abstract][Full Text] [Related]
19. A-to-I RNA editing shows dramatic up-regulation in osteosarcoma and broadly regulates tumor-related genes by altering microRNA target regions.
Ge F; Cao X; Jiang Y
J Appl Genet; 2023 Sep; 64(3):493-505. PubMed ID: 37542613
[TBL] [Abstract][Full Text] [Related]
20. miR-EdiTar: a database of predicted A-to-I edited miRNA target sites.
Laganà A; Paone A; Veneziano D; Cascione L; Gasparini P; Carasi S; Russo F; Nigita G; Macca V; Giugno R; Pulvirenti A; Shasha D; Ferro A; Croce CM
Bioinformatics; 2012 Dec; 28(23):3166-8. PubMed ID: 23044546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
